Role of reactive oxygen species in aging and age-related diseases: A review
Research on the role of reactive oxygen species (ROS) in the aging process has advanced
significantly over the last two decades. In light of recent findings, ROS takes part in the aging …
significantly over the last two decades. In light of recent findings, ROS takes part in the aging …
Programmed axon degeneration: from mouse to mechanism to medicine
MP Coleman, A Höke - Nature Reviews Neuroscience, 2020 - nature.com
Wallerian degeneration is a widespread mechanism of programmed axon degeneration. In
the three decades since the discovery of the Wallerian degeneration slow (Wld S) mouse …
the three decades since the discovery of the Wallerian degeneration slow (Wld S) mouse …
Mitochondrial dysfunction as a trigger of programmed axon death
Mitochondrial failure has long been associated with programmed axon death (Wallerian
degeneration, WD), a widespread and potentially preventable mechanism of axon …
degeneration, WD), a widespread and potentially preventable mechanism of axon …
Cytoplasmic and mitochondrial NADPH-coupled redox systems in the regulation of aging
PC Bradshaw - Nutrients, 2019 - mdpi.com
The reduced form of nicotinamide adenine dinucleotide phosphate (NADPH) protects
against redox stress by providing reducing equivalents to antioxidants such as glutathione …
against redox stress by providing reducing equivalents to antioxidants such as glutathione …
Neuroprotective effects of resveratrol in in vivo and in vitro experimental models of Parkinson's disease: A systematic review
MG Dos Santos, LE Schimith, C André-Miral… - Neurotoxicity …, 2022 - Springer
Parkinson's disease (PD) is currently the second most common neurodegenerative disease,
being characterized by motor and non-motor symptoms. The therapeutic options available …
being characterized by motor and non-motor symptoms. The therapeutic options available …
Loss of oxidation resistance 1, OXR1, is associated with an autosomal-recessive neurological disease with cerebellar atrophy and lysosomal dysfunction
J Wang, J Rousseau, E Kim, S Ehresmann… - The American Journal of …, 2019 - cell.com
We report an early-onset autosomal-recessive neurological disease with cerebellar atrophy
and lysosomal dysfunction. We identified bi-allelic loss-of-function (LoF) variants in …
and lysosomal dysfunction. We identified bi-allelic loss-of-function (LoF) variants in …
Senolytic and senomorphic secondary metabolites as therapeutic agents in Drosophila melanogaster models of Parkinson's disease
SJ Miller, RY Darji, S Walaieh, JA Lewis… - Frontiers in …, 2023 - frontiersin.org
Drosophila melanogaster is a valuable model organism for a wide range of biological
exploration. The well-known advantages of D. melanogaster include its relatively simple …
exploration. The well-known advantages of D. melanogaster include its relatively simple …
Adult health and transition stage-specific rotenone-mediated Drosophila model of Parkinson's disease: Impact on late-onset neurodegenerative disease models
M Ayajuddin, L Phom, Z Koza, P Modi, A Das… - Frontiers in molecular …, 2022 - frontiersin.org
Parkinson's disease (PD) affects almost 1% of the population worldwide over the age of 50
years. Exposure to environmental toxins like paraquat and rotenone is a risk factor for …
years. Exposure to environmental toxins like paraquat and rotenone is a risk factor for …
Mitochondrial localization of SARM1 in acrylamide intoxication induces mitophagy and limits neuropathy
S Wang, M Song, H Yong, C Zhang, K Kang, Z Liu… - Molecular …, 2022 - Springer
Sterile α and toll/interleukin 1 receptor motif-containing protein 1 (SARM1) is the defining
molecule and central executioner of programmed axon death, also known as Wallerian …
molecule and central executioner of programmed axon death, also known as Wallerian …